Kousuke Onoue

Title: Kousuke Onoue: Innovator in Neoantigen-Based Immunotherapy

Introduction

Kousuke Onoue is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of immunotherapy, particularly in the development of personalized cancer treatments. His innovative approach focuses on targeting neoantigens to enhance immune responses in cancer patients.

Latest Patents

Kousuke Onoue holds a patent for a method and system of targeting epitopes for neoantigen-based immunotherapy. This patent outlines a method of ranking epitopes derived from neoantigens as targets for personalized immunotherapy. The process involves collecting candidate epitopes based on patient data of a cancer patient. A set of scores is calculated for each candidate epitope, representing an independent measure of the likelihood of eliciting an immune response in the patient. These scores are then combined into a single score for each candidate epitope, reflecting the overall likelihood of eliciting an immune response. The candidate epitopes are subsequently ranked using these single scores to optimize immunotherapy.

Career Highlights

Kousuke Onoue is currently employed at NEC Corporation, where he continues to advance his research in immunotherapy. His work is pivotal in the ongoing efforts to personalize cancer treatment, making significant strides in the medical field.

Collaborations

Kousuke collaborates with notable colleagues, including Yoshiko Yoshihara and Brandon Malone. Their combined expertise contributes to the innovative research and development of new therapeutic methods.

Conclusion

Kousuke Onoue's contributions to neoantigen-based immunotherapy exemplify the potential of personalized medicine in cancer treatment. His innovative methods and collaborative efforts are paving the way for more effective immunotherapy solutions.